Literature DB >> 31029184

Cognitive Behavioral Therapy for Insomnia in Patients with Medical and Psychiatric Comorbidities.

Greta B Raglan1, Leslie M Swanson1, John Todd Arnedt2.   

Abstract

"Insomnia is highly comorbid with other mental health and medical conditions and adversely affects quality of life and daytime functioning. Cognitive behavioral therapy for insomnia (CBT-I) is a safe and efficacious treatment for insomnia in the context of various comorbid conditions. In this article, the authors outline considerations for delivering CBT-I in patients with the most common co-occurring medical and mental health conditions, review the evidence for CBT-I in these populations as well as special considerations for its application, and highlight future areas for research in the area of CBT-I for comorbid medical and psychiatric conditions."
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive behavioral therapy for insomnia (CBT-I); Comorbid; Comorbidity; Depression; Diagnosis; Disorder; Insomnia

Mesh:

Year:  2019        PMID: 31029184     DOI: 10.1016/j.jsmc.2019.01.001

Source DB:  PubMed          Journal:  Sleep Med Clin        ISSN: 1556-407X


  3 in total

1.  Sleep, Stress, and Symptoms Among People With Heart Failure During the COVID-19 Pandemic.

Authors:  Meghan O'Connell; Sangchoon Jeon; Samantha Conley; Sarah Linsky; Nancy S Redeker
Journal:  J Cardiovasc Nurs       Date:  2022-03-24       Impact factor: 2.468

2.  TIMELAPSE study-efficacy of low-dose amitriptyline versus cognitive behavioral therapy for chronic insomnia in patients with medical comorbidity: study protocol of a randomized controlled multicenter non-inferiority trial.

Authors:  Nynke L Rauwerda; Hans Knoop; Irene Pot; Annemieke van Straten; Marian E Rikkert; Anouk Zondervan; Thom P J Timmerhuis; Annemarie M J Braamse; H Myrthe Boss
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.279

3.  Effects of schedule exercise therapy on chronic insomnia.

Authors:  Yuan-Gao Liao; Feng-Zhen Huang; Xiao-Hong Ni; Hong-Yan Ke; Yu Tian; Mei Yu; Guo Jin; Gui-Hai Chen
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.